Display options
Share it on

Thromb J. 2016 Oct 04;14:38. doi: 10.1186/s12959-016-0093-1. eCollection 2016.

Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venom.

Thrombosis journal

Ren-Chieh Wu, Ping-Tse Chou, Li-Kuang Chen

Affiliations

  1. Department of Emergency Medicine, Tzu Chi Medical Center, Hualien, Taiwan.
  2. Department of Laboratory Diagnosis, School of Medicine, Tzu Chi University, Hualien, Taiwan.
  3. Department of Emergency Medicine, Tzu Chi Medical Center, Hualien, Taiwan ; Department of Laboratory Diagnosis, School of Medicine, Tzu Chi University, Hualien, Taiwan ; Branch of Clinical Pathology, Department of Laboratory Medicine, Tzu Chi Medical Center, Hualien, Taiwan.

PMID: 27766063 PMCID: PMC5056472 DOI: 10.1186/s12959-016-0093-1

Abstract

BACKGROUND: Thrombosis and coagulopathy are the commonest hematological manifestations of envenomation of Russell's viper venom (RVV). Factor X is activated by a factor X-activating enzyme from Russell's viper venom (RVV-X) to start the coagulation cascade. We established an animal model with local ischemic effects induced by RVV. We tried to treat RVV envenomation with antiplatelets and anticoagulants without recourse to antivenom.

METHODS: RVV was injected into the foot pad of mice. We observed the effects at different intervals and compared local changes in ischemia with drug treatment after 30 min.

RESULTS: A combination of aspirin plus tirofiban could prevent the ischemic change induced by RVV. The antithrombotic effects of single-use of aspirin or tirofiban were better than single-use of heparin or clopidogrel.

CONCLUSION: The aspirin + tirofiban group had a better outcome with respect to prevention of tissue ischemia and gangrene. This indicates that the activation and aggregation of platelets is the major cause of thrombosis induced by RVV.

Keywords: Antiplatelet; Mouse model; Russell’s viper venom; Thrombosis

References

  1. Trans R Soc Trop Med Hyg. 2004 Feb;98(2):96-101 - PubMed
  2. Pharmacol Toxicol. 2002 Sep;91(3):106-10 - PubMed
  3. Neurol India. 2009 Jul-Aug;57(4):479-80 - PubMed
  4. N Engl J Med. 1989 Feb 9;320(6):352-7 - PubMed
  5. Lancet. 1960 Jun 18;1(7138):1309-12 - PubMed
  6. J Biol Chem. 1992 Jul 15;267(20):14109-17 - PubMed
  7. Toxicon. 1997 Mar;35(3):319-40 - PubMed
  8. Stroke. 2007 May;38(5):1655-711 - PubMed
  9. N Engl J Med. 1986 Oct 30;315(18):1109-14 - PubMed
  10. Vasc Med. 1998;3(3):247-51 - PubMed
  11. J Biol Chem. 1994 Jul 29;269(30):19256-61 - PubMed
  12. PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3220 - PubMed
  13. Haemostasis. 2001 May-Dec;31(3-6):225-33 - PubMed
  14. Trans R Soc Trop Med Hyg. 2006 May;100(5):489-94 - PubMed
  15. Q J Med. 1988 Sep;68(257):691-715 - PubMed
  16. Toxicon. 2011 Sep 1;58(3):230-8 - PubMed
  17. Br J Haematol. 1961 Oct;7:496-511 - PubMed
  18. Blood. 2001 Dec 1;98(12):3340-5 - PubMed
  19. BMJ. 2002 Jan 12;324(7329):71-86 - PubMed
  20. J Am Coll Cardiol. 2007 Aug 14;50(7):e1-e157 - PubMed
  21. Methods Enzymol. 1976;45:191-205 - PubMed
  22. Toxicon. 2002 Sep;40(9):1291-8 - PubMed
  23. Toxicon. 2009 Sep 15;54(4):421-8 - PubMed
  24. Lancet. 1985 Dec 7;2(8467):1259-64 - PubMed
  25. Blood. 1998 Jul 1;92(1):152-9 - PubMed
  26. N Engl J Med. 1991 May 30;324(22):1565-74 - PubMed
  27. Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):732-40 - PubMed
  28. Acta Trop. 1989 Jan;46(1):23-38 - PubMed
  29. Cell Signal. 2000 Jun;12(6):351-60 - PubMed
  30. Toxicon. 1997 Nov;35(11):1581-9 - PubMed
  31. N Engl J Med. 1988 Oct 27;319(17):1105-11 - PubMed
  32. Circulation. 2002 May 28;105(21):2531-6 - PubMed
  33. Circ Res. 2002 Mar 8;90(4):428-34 - PubMed
  34. Semin Thromb Hemost. 2010 Jun;36(4):444-51 - PubMed

Publication Types